Change in healthcare utilization and costs following initiation of benzodiazepine therapy for long-term treatment of generalized anxiety disorder: a retrospective cohort study

BACKGROUND: Selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and benzodiazepine anxiolytics are used in the US to treat generalized anxiety disorder (GAD). While benzodiazepines typically provide rapid symptomatic relief, long-term use is not recommended due to...

Descripción completa

Detalles Bibliográficos
Autores principales: Berger, Ariel, Edelsberg, John, Treglia, Michael, Alvir, Jose Ma J, Oster, Gerry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504522/
https://www.ncbi.nlm.nih.gov/pubmed/23088742
http://dx.doi.org/10.1186/1471-244X-12-177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504522/
https://www.ncbi.nlm.nih.gov/pubmed/23088742
http://dx.doi.org/10.1186/1471-244X-12-177

Ejemplares similares